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Abstract
The maltose ATP-binding cassette (ABC) transporter of Salmonella typhimurium is composed of a membrane-associated complex
(MalFGK2) and a periplasmic substrate binding protein. To further elucidate protein–protein interactions between the subunits, we have
studied the dissociation and reassembly of the MalFGK2 complex at the level of purified components in proteoliposomes. First, we optimized
the yield in purified complex protein by taking advantage of a newly constructed expression plasmid that carries the malK, malF and malG
genes in tandem orientation. Incorporated in proteoliposomes, the complex exhibited maltose binding protein/maltose-dependent ATPase
activity with a Vmax of 1.25 Amol Pi/min/mg and a Km of 0.1 mM. ATPase activity was sensitive to vanadate and enzyme IIAGlc, a component
of the enterobacterial glucose transport system. The proteoliposomes displayed maltose transport activity with an initial rate of 61 nmol/min/
mg. Treatment of proteoliposomes with 6.6 M urea resulted in the release of medium-exposed MalK subunits concomitant with the complete
loss of ATPase activity. By adding increasing amounts of purified MalK to urea-treated proteoliposomes, about 50% of vanadate-sensitive
ATPase activity relative to the control could be recovered. Furthermore, the phenotype of MalKQ140K that exhibits ATPase activity in
solution but not when associated with MalFG was confirmed by reassembly with MalK-depleted proteoliposomes.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The family of ATP-binding-cassette (ABC) transport
systems comprises an extremely diverse class of membrane
proteins that couple the energy of ATP hydrolysis to the
translocation of solutes across biological membranes (for
recent reviews, see Refs. [1,2]). Prominent members of the
family include the P-glycoprotein (MDR) involved in multi-
drug resistance of certain cancer cells [3], the cystic fibrosis
transmembrane regulator protein (CFTR) which is mutated
in patients affected by cystic fibrosis [4], the TAP1–TAP2
peptide transporter, associated with antigen presentation [5],
and the subfamily of binding protein-dependent ABC trans-
port systems that mediate the uptake of a large variety of
nutrients in prokaryotes [6].
A prototype ABC transporter is composed of four enti-
ties: two membrane-integral domains that presumably con-
stitute a translocation pore, and two ATPase domains (also
referred to as ABC subunits/domains), that provide the
energy for the transport process. The ABC domains are
characterized by a unique ‘‘signature sequence’’ (LSGGQ
motif) of still unknown function [7]. The crystal structures
of several prokaryotic ABC domains have recently been
solved that agree largely on the overall folds. Accordingly,
the structures can be subdivided in an F1-type ATP-binding
domain, encompassing both nucleotide binding motifs
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(‘‘Walker’’ A and B sites), a specific a-helical sub-domain,
encompassing the LSGGQ motif and a specific antiparallel-
h-subdomain [8–11].
In export systems, these modules are mostly fused to
yield a single polypeptide chain, while prokaryotic ABC
importers are built up from individual subunits [1,2]. The
latter also require an additional extracellular (periplasmic)
substrate-binding protein for activity [6].
The binding protein-dependent maltose/maltodextrin
transporter of enterobacteria, such as Escherichia coli and
Salmonella typhimurium, is a well-characterized model
system for studying the mechanism of action of ABC
transporters. Based on computational analysis, it belongs
to a subclass of ABC importers designated CUT1 (carbohy-
drate uptake transporter) [12] or OSP (oligosaccharides and
polyols) [13], respectively. Members of this subclass trans-
port a variety of di- and oligosaccharides, glycerol phos-
phate and polyols and are recognized by their common
subunit composition (two individual membrane-spanning
subunits and two copies of a single ABC protein) and by
an extension of approximately hundred amino acid residues
at the C-terminus of the ABC protein [14].
The maltose transporter of E. coli/S. typhimurium is
composed of the periplasmic maltose binding protein, MalE,
and of the membrane-associated complex, MalFGK2, con-
sisting of one copy each of the hydrophobic subunits MalF
and MalG and two copies of the nucleotide-binding subunit
MalK [15,16]. Crystals of Salmonella MalK are available
[17] but their structure could not be solved yet. However,
the tertiary structure of a MalK homolog, isolated from the
hyperthermophilic archaeon Thermococcus litoralis, was
recently determined [9]. Two molecules are present per
asymmetric unit that contact each other through the ATPase
domains with the C-terminal domains attached at opposite
poles. According to current transport models, the presence
of substrate in the medium is thought to be signaled by
liganded MalE via interaction with externally exposed
peptide loops of MalF and MalG [18]. As a consequence,
conformational changes of the latter are transmitted to the
MalK subunits which, in turn, become activated. Hydrolysis
of ATP would then trigger subsequent conformational
changes that eventually lead to the translocation of the
substrate molecule. Recent findings suggested that these
steps occur rather simultaneously [19].
Assembly of the MalFGK2 complex in vivo requires the
initial formation of a MalK dimer that subsequently interacts
with membrane-associated MalFG [20]. The latter sponta-
neously incorporate in the membrane alone, although the
conformation of MalF is different when produced together
with MalG [21]. When studied in membrane vesicles con-
taining MalFG, binding of purified MalK was favoured in
the presence of ATP [22]. Interaction of MalK with the
hydrophobic subunits involves contact of residues in the
helical subdomain connecting the Walker A and B motifs
with conserved cytoplasmic loops (‘‘EAA’’ motifs) in MalF
and MalG [23–25].
Purified MalK displays a low spontaneous ATPase ac-
tivity that is insensitive to vanadate [26–28], while in the
MalFGK2 complex, when incorporated into liposomes, ATP
hydrolysis and ligand translocation are coupled, dependent
on the binding protein, and vanadate-sensitive [16,28].
Moreover, ATP is hydrolyzed cooperatively [29] and two
intact copies of the MalK subunit are required for activity
[30].
Besides acting as an import system for maltose/malto-
dextrins, the MalFGK2 complex is involved in the regula-
tion of genes belonging to the maltose regulon by
interaction of the MalK subunits with the positive transcrip-
tional regulator, MalT [15,31]. Furthermore, the maltose
transporter is subject to inhibition by enzyme IIA of the
glucose transporter in a process called ‘inducer exclusion’ in
the context of global carbon regulation in enteric bacteria
[15,32]. Both activities are largely mediated by the C-
terminal domain of the MalK subunits [33–35].
Obviously, specific interactions between the individual
subunits as well as between the transporter and regulatory
proteins are crucial for its role in intact cells. However, such
interactions have, thus far, mostly been studied at the level
of whole cells or membrane vesicles. Here, we describe for
the first time the dissociation and reassembly of the purified
MalFGK2 transporter of S. typhimurium in proteoliposomes.
The procedure will allow further studies on protein–protein
interactions with purified components. Moreover, and as a
prerequisite for these experiments, we report the construc-
tion of a new expression vector by which the yield in
purified transport complex was substantially increased.
2. Materials and methods
2.1. Bacterial strains and plasmids
All cloning steps were carried out in E. coli strain JM109
(Stratagene). Plasmid pBB1 (pT5 malKht, ptrc, malFmalG,
ampr) was constructed by ligating a SalI restriction fragment
of pIG1 (ptrc, malFmalG, amp
r; derivative of pKK233-2,
Go¨hling and Schneider, unpublished) with plasmid pGS91-
1 (pT5 malKht, amp
r, Ref. [36]), previously digested with the
same enzyme.
2.2. Purification of the MalFGK2 complex
Cells of strain JM109(pBB1) were grown in tryptone-
phosphate medium [37] at 37 jC to an OD650 = 0.25.
Expression of malK, malF, malG was induced by the
addition of 0.5 mM IPTG and growth continued to
OD650 = 4. Cells were harvested by centrifugation for 10
min at 9000 g, resuspended in 150 ml of buffer 1 [50 mM
Tris–HCl, pH 8, 5 mM MgCl2, 20% glycerol, 0.1 mM
phenylmethylsulfonyl fluoride (PMSF)] and disruptured by
one passage through a French Press at 18,000 psi. Following
a low speed spin for 15 min at 10,000 g, membrane
H. Landmesser et al. / Biochimica et Biophysica Acta 1565 (2002) 64–72 65
vesicles were recovered by centrifugation for 1 h at
200,000 g, resuspended in buffer 1 and stored at  80
jC until use. Solubilization of the transport complex was
achieved by adding n-dodecyl-h-D-maltoside (DM, final
concentration: 1.1%) (Biomol) [36,38] to membrane
vesicles at 5 mg/ml in buffer 1. After incubation for 1 h
on ice under constant stirring, solubilized proteins were
separated from the remaining membranes by ultracentrifu-
gation for 1 h at 200,000 g. The supernatant was then
mixed with Ni-nitrilo triacetic acid (NTA) agarose (Qiagen)
(1 ml of slurry per 9 ml of supernatant), equilibrated with
buffer 1 containing 0.01% DM (buffer 2) and incubated for
1 h on a shaking device in a cold room. Subsequently, the
mixture was poured into a disposable column and the
matrix was washed with 15 bed volumes of buffer 2, fol-
lowed by 15 bed volumes of buffer 2 containing 20 mM
imidazol. The transport complex was finally eluted with 15
bed volumes of buffer 2 supplemented with 50 mM imida-
zole. Peak fractions were combined, concentrated by ultra-
filtration through Amicon filter YM30 and dialyzed against
buffer 2 (500 the sample volume). Finally, the protein
was shock-frozen in liquid nitrogen and stored at  80 jC.
2.3. Purification of MalK variants
Wild-type MalK and variant Q140K were purified by a
published procedure [37].
2.4. Purification of MalE
Maltose binding protein was purified from the osmotic
shock fluid of the overproducing strain MM134(pES35)
[28] as described in Ref. [39]. For some experiments,
purified MalE was subjected to a denaturation/renaturation
procedure [38] to remove tightly bound maltose.
2.5. Preparation of proteoliposomes
The MalFGK2 complex was incorporated into liposomes
by a detergent dilution procedure according to Ref. [38].
Typically, the reconstitution mixture (300 Al) contained
liposomes (2.5 mg) preformed by ultrasonication from L-
a-phosphatidylcholine Type IV-S (Sigma P-3644), 1% (w/v)
octylglucoside, 50 Ag purified MalFGK2 complex, 120 Ag
maltose binding protein (MalE) and 60 mM maltose in 20
mM Tris–HCl, pH 8. After incubation for 30 min on ice
under gentle stirring, 25 ml of 20 mM Tris–HCl, pH 8, 1
mM dithiothreitol (DTT) were added and the mixture was
centrifuged for 1 h at 200,000 g. Proteoliposomes formed
by this procedure were resuspended in 100 Al of 20 mM
Tris–HCl, pH 8, 1 mM MgCl2, 10 AM maltose and
analyzed for ATPase activity as described below.
Proteoliposomes for measuring maltose transport activity
were essentially prepared as above with the following
modifications: maltose binding protein and maltose were
replaced by 5 mM ATP and after centrifugation, the pro-
teoliposomes were resuspended in 100 Al of 20 mM Tris–
HCl, pH 8, 3 mM MgCl2.
2.6. Preparation of MalK-depleted proteoliposomes and
reassembly with MalK variants
Proteoliposomes prepared as described above were resus-
pended in 50 mM Tris–HCl, pH 8, containing 100 mM
NaCl and 6.6 M urea to a final volume of 400 Al. The
mixture was gently stirred for 45 min on ice, diluted with
3.5 ml of 50 mM Tris–HCl, pH 8, 100 mM NaCl and
MalK-depleted proteoliposomes were collected by centrifu-
gation for 1 h at 300,000 g. After resuspending the pellet
in 100 Al of the same buffer, purified wild-type MalK or
variant (10–200 Ag) were added and the mixture was
incubated for 1 h on ice, diluted with 1 ml buffer and
centrifuged as above. Finally, the proteoliposomes were
resuspended in 100 Al of 20 mM Tris–HCl, pH 8, 1 mM
MgCl2, 10 AM maltose and assayed for ATPase activity and
protein content by sodium dodecylsulfate polyacrylamide
gel electrophoresis (SDS-PAGE).
2.7. Urea treatment of everted membrane vesicles
Everted membrane vesicles of strain JM109(pBB1) were
prepared as described above and treated with varying con-
centrations of urea essentially as described in Ref. [40].
Briefly, membrane vesicles (10 mg/ml) were incubated in 50
mM 4-morpholinepropanesulfonic acid (MOPS)–KOH, pH
7, 100 mM NaCl, 1 mM DTT, 0.2 mM PMSF, containing
the urea concentrations as indicated, for 1 h on ice. Sub-
sequently, urea-soluble and urea-insoluble fractions were
separated by ultracentrifugation for 30 min at 200,000 g
and subjected to SDS-PAGE. Detection of MalK and MalF
was achieved by immunoblotting using polyclonal antibody
raised against the respective proteins. Proteins were visual-
ized by chemiluminescence (ECL, Amersham).
2.8. Analytical methods
Hydrolysis of ATP was assayed in microtiter plates es-
sentially as described in Ref. [41].
The uptake of 14C-maltose (10 AM; 0.86 ACi) in proteo-
liposomes was performed in 20 mM Tris–HCl, pH 8, 3 mM
MgCl2, in the presence of 1 AM MalE essentially as de-
scribed in Ref. [42].
Protein was assayed by using the BCA kit from BioRad.
SDS-PAGE and immunoblot analyses were performed as
described in Ref. [42]. For better separation of His6-MalK,
MalK, MalF and MalE from proteoliposomes, the pH of the
separating gel was lowered to 8.4.
Quantitation of protein bands from proteoliposomes on
SDS gels or immunoblots was carried out with the E.A.S.Y.
Plus system (Herolab) using the software supplied by the
manufacturer. Samples of purified MalK with known pro-
tein concentrations were run on the same gels and used as
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standards. To correct for losses in proteoliposomes during
the centrifugation step (see above), the calculated amounts
of MalK protein were multiplied by a factor representing the
ratio of the amounts of MalF protein present before and after
centrifugation.
Competitive inhibition enzyme-linked immunosorbent
assay (ELISA) was essentially carried out as described in
Ref. [43].
3. Results
3.1. Large-scale purification and enzymatic properties of
the MalFGK2 complex
As a prerequisite for the intended study, we first set out to
increase the yield in purified MalFGK2 complex protein.
Previously, two compatible plasmid vectors, bearing the
malK gene (pGS91-1) and the malFmalG genes (pES62),
respectively, were introduced into an E. coli host strain to
achieve amplification of the transport proteins [36]. How-
ever, hardly controllable variations in plasmid copy numbers
affected the stoichiometry of the gene products and resulted
in inconsistent and rather low amounts of overproduced
proteins. Thus, to eliminate these problems, we placed the
malFmalG genes in a tandem orientation to malK on
plasmid pGS91-1, yielding plasmid vector pBB1 (see
Materials and Methods for details). Cells of E. coli strain
JM109, transformed with pBB1 and grown to OD650 = 4
after induction of mal gene expression with IPTG typically
yielded about 200 mg of membrane proteins per liter
culture. From these, 4.5 mg of highly purified transport
complex was routinely obtained (see also Fig. 1, insert).
Compared to the two-plasmid expression system that, on
average, allowed the purification of 0.6 mg of complex
protein per liter culture, this corresponds to a 7–8-fold in-
crease in protein yield.
The purified transporter displayed a low intrinsic ATPase
activity in detergent solution (0.036 Amol Pi/min/mg pro-
tein) that could be stimulated 5-fold by the addition of
maltose loaded MalE (Fig. 1). When incorporated into
liposomes, the spontaneous rate of ATP hydrolysis was
0.03 Amol Pi/min/mg which could be substantially increased
by loading the proteoliposomes with liganded MalE. Under
these conditions, a Vmax of 1.25 Amol/min/mg of protein and
a Km of 0.1 mM were obtained. The latter value is in
excellent agreement with Michaelis constants reported for
the purified MalK subunit (0.07–0.1 mM) [27,37].
In the absence of maltose, MalE was also capable to
initiate ATP hydrolysis (0.39 Amol Pi/min/mg of protein).
Fig. 1. ATPase activity of the purified MalFGK2 complex. ATP hydrolysis catalyzed by the MalFGK2 complex in proteoliposomes or in detergent solution was
analyzed by monitoring the release of inorganic phosphate as described under Materials and Methods. Symbols: open circles, MalE/maltose-loaded MalFGK2-
containing proteoliposomes; closed squares, MalE-loaded MalFGK2-containing proteoliposomes; closed circles, MalFGK2 complex in detergent solution in the
presence of MalE/maltose; open squares, MalFGK2 complex in detergent solution; open triangles, MalFGK2-containing proteoliposomes. Insert: Silver-stained
SDS gel of the purified preparation (2 Ag).
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This was not due to residual, tightly bound maltose as a
MalE preparation that was subjected to a denaturation/
renaturation procedure displayed essentially the same activ-
ity. Thus, and in agreement with other data [44], the
unliganded binding protein interacts with the membrane-
bound complex.
The Vmax value given above is based on the assumption
that all added complex protein was incorporated into lip-
osomes. However, quantitation of MalK in SDS gels re-
vealed that only 46% of the protein was actually recovered
with the proteoliposomes (average of 10 independent ex-
periments). Moreover, as determined by competitive inhib-
ition ELISA, only 50% of the incorporated transport
complexes were oriented with the MalK subunits facing
the medium and thus contributed to the enzymatic activity
(average of two independent experiments). Taking these
numbers into account, the actual Vmax value for ATP hy-
drolysis would be 5.4 Amol Pi/min/mg of protein.
The ATPase activity of the purified MalFGK2 complex in
proteoliposomes was sensitive to vanadate with half-max-
imal inhibition at 60 AM. Furthermore, purified enzyme
IIAGlc of E. coli (kindly provided by F. Titgemeyer) also
strongly reduced the ATPase activity, reaching 50% inhib-
ition at 0.3 Ag (Fig. 2). In contrast, soluble MalK was hardly
affected (18% inhibition in the presence of 0.6 Ag enzyme
IIAGlc per microgram MalK). From these data, it was cal-
culated that a 25-fold molar excess of enzyme IIAGlc
(molecular mass: 18.2 kDa) over MalFGK2 (molecular mass:
171 kDa) would be required for full inhibition. This value is
close to the ratio of 18 determined for whole cells [45].
Finally, we demonstrated that the observed MalE/mal-
tose-dependent ATPase activity of the transport complex in
proteoliposomes was coupled to the uptake of radiolabelled
maltose. An initial rate of uptake of 61 nmol/min/mg of
protein (average of three experiments) was measured. This
rate is more than an order of magnitude higher than that
reported for the E. coli transporter (1.2 nmol/min/mg of
protein) [19,30]. As both preparations exhibit similar ATPase
activities, we conclude that the preparation described here
displays a better coupling between ATP hydrolysis and
substrate translocation. Again, when taking into account
the amount of transport proteins incorporated into liposomes
and the fact that only 50% of the molecules are in an
orientation that can contribute to the activity, the actual rate
would be 266 nmol/min/mg.
Together, we conclude that the transport complex puri-
fied by the procedure described has all the earmarks of a
functionally coupled system and thus, is suited for studying
dissociation and reassembly processes.
3.2. Dissociation of the MalFGK2 complex in proteolipo-
somes
To gain further insight into subunit–subunit interactions
in the transport complex, we set out to develop a protocol
Fig. 2. Inhibition of MalE-maltose-stimulated ATPase activity by purified
enzyme IIAGlc. Proteoliposomes (corresponding to 1 Ag of complex protein
originally mixed with phospholipids) (open circles) or MalK (1 Ag) (closed
circles) were incubated with the indicated amounts of enzyme IIAGlc at 37
jC for 5 min and subsequently assayed for ATPase activity under standard
conditions. Control activities (100%) were 1.1 and 0.13 Amol Pi/min/mg for
proteoliposomes and MalK, respectively.
Fig. 3. Dissociation and reassembly of MalFGK2 complex. (A) Removal of
MalK from everted membrane vesicles of strain JM109(pBB1) by urea. See
Materials and Methods for details. Immunoblots developed for detection of
MalK (upper part) and MalF (lower part) are shown. T, total membranes
(control); S, supernatant (urea-soluble fraction); P, pellet (urea-insoluble
fraction). (B) Depletion of MalK from proteoliposomes and rebinding. An
SDS-PAGE of a typical experiment is shown. Intact MalFGK2-containing
proteoliposomes (PLS) were treated with 6.6 M urea to remove exposed
His6-MalK and subsequently reassembled with increasing concentrations of
purified (tagless) MalK as described under Materials and Methods (lanes
1–5). Control liposomes lacking the transport complex were incubated with
MalK under the same conditions (lanes 6–8). Please note that under the
conditions used to separate His6-MalK, MalF and MalK, the MalG protein
runs out of the gel. St, molecular weight markers ( 103).
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Fig. 4. Quantitative analysis of rebinding of MalK to MalFG-containing proteoliposomes. (A) Reassociation of increasing amounts of MalK with FG-
containing proteoliposomes and control liposomes, respectively, was carried out as described under Materials and Methods. After centrifugation to remove
unbound MalK, proteoliposomes and liposomes were subjected to SDS-PAGE and stained with Coomassie blue. Quantitation of bound MalK was determined
by densitometric scanning, using samples of purified MalK of known protein concentrations as standards. Binding of low amounts of MalK (1–8 Ag) was
quantitated by analyzing immunoblots developed with the ECL chemoluminescence kit (Amersham). (B) Scatchard analysis of the data given in (A).
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for the removal of MalK from proteoliposomes. Initial
experiments using inside-out membrane vesicles of strain
JM109(pBB1) had shown that up to 69% of MalK was
released from MalFG by treatment with 6.6 M urea (Fig.
3A, upper part). The residual amount of membrane-associ-
ated MalK could neither be extracted by adding MgATP (15
mM each) nor by raising the urea concentration to 7.3 M.
Possibly, the subpopulation of MalK that resists solubiliza-
tion by urea is either aggregated and/or unspecifically
associated with the membrane. Under the conditions used,
most if not all MalF was recovered with the pellet fractions
suggesting that treatment with urea did not result in sig-
nificant desintegration of the membrane (Fig. 3A, lower
part).
When similar experiments were performed with MalE/
maltose loaded proteoliposomes containing the purified
MalFGK2 complex, incubation with 6.6 M urea resulted
in the complete loss of ATPase activity. In contrast, proteo-
liposomes treated with lower concentrations of urea (3.6–5
M) exhibited residual ATPase activities (0.6–0.35 Amol Pi/
min/mg), suggesting incomplete dissociation of MalK.
Again, the presence of MgATP did not change these results.
Quantitation by densitometric scanning of SDS gels of the
amount of MalK present in the proteoliposomes before and
after treatment with 6.6 M urea revealed that 46% of total
MalK (average of four experiments) were removed (Fig. 3B,
lanes 1 and 2). Since only half of the complex molecules
contribute to the enzymatic activity (see above), we con-
clude that the proteoliposomes were fully depleted of
medium-exposed MalK subunits.
3.3. Reassembly of a functional transport complex with
purified MalK
MalK-depleted proteoliposomes were then incubated
with increasing concentrations of purified MalK protein to
study reassembly of a functional complex. To distinguish
between residual and newly bound MalK proteins, a tag-less
variant that migrates faster in SDS gels was used. As shown
in Figs. 3B (lanes 3–5) and 4A, increasing amounts of
MalK associated with the MalFG-containing proteolipo-
somes. Concomitantly, MalE/maltose-dependent and vana-
date-sensitive ATPase activity was recovered that, at
maximum, corresponded to 53% of the activity measured
with intact proteoliposomes (Fig. 5). Recovery of enzymatic
activity could not be increased by the presence of MgATP
during reassembly. Control experiments revealed that MalK
also associates with MalE/maltose loaded liposomes lacking
MalFG, but only at higher concentrations and to a lesser
extent (Fig. 3B, lanes 6–8, and Fig. 4A). However, and
most importantly, these liposomes did not hydrolyze ATP
(Fig. 5). Taking into account that purified MalK exhibits an
intrinsic ATPase activity (0.2 Amol Pi/min/mg), lipid
actually inhibited this activity. A similar result was reported
for the homologous HisP subunit of the histidine transporter
of S. typhimurium [41].
Scatchard plot analysis of data shown in Fig. 4A revealed
that 1.2 mol of MalK reassociated with 1 mol of MalFG
complex (Fig. 4B), rather than 2 mol as in the native
complex [16]. This finding is consistent with the 53% of
ATPase activity that was maximally recovered. Thus, about
half of the MalK-depleted MalFG complexes retained the
capability to functionally interact with MalK.
3.4. Reassembly with the MalKQ140K variant
With a protocol for dissociation of the MalFGK2 com-
plex at hand, we then studied the reassembly process with a
MalK mutant protein. The MalKQ140K variant was
recently shown to exhibit normal intrinsic ATPase activity
in the soluble state but largely failed to hydrolyze ATP when
assembled with MalFG [36]. Thus, the mutation might
cause a defect in the activation of ATPase activity upon
interaction of the complex with liganded MalE. Conse-
quently, reassembly with MalFG should result only in a
low recovery of MalE/maltose-dependent ATPase activity.
As shown in Fig. 4, this was indeed the case.
4. Discussion
In this communication, we describe the dissociation and
functional reassembly of the MalFGK2 complex of S.
typhimurium. To our knowledge, this is the first report on
such a study for a multi-subunit ABC transporter at the level
of purified components in proteoliposomes. Treatment with
6.6 M urea resulted in complete extraction of exposed MalK
proteins as judged from the loss in MalE/maltose-dependent
ATPase activity and from quantitation of residual MalK in
SDS gels. These data basically confirmed the results
obtained with membrane vesicles of strain JM109(pBB1)
of which the majority of MalK protein was released under
the same conditions. Urea was also the preferred chaotrope
to dissociate the MalK-homolog HisP of the histidine trans-
porter of S. typhimurium in inside-out membrane vesicles
[40]. Here, only low amounts of HisP protein were recov-
ered with the soluble fraction after treatment with 3.6 M
urea and even 7.3 M urea did not release more than 40% of
HisP. However, addition of MgATP to 6.6 M urea extracted
essentially all HisP [40]. These and other data led the
authors to conclude that HisP is rather tightly bound to its
cognate membrane-integral components HisQM but
becomes disengaged upon binding of MgATP [46]. Clearly,
such a notion is not consistent with our results. Rather, in
the case of the maltose transporter, the more efficient
solubilization of MalK by the same concentration of urea
both in membrane vesicles and in proteoliposomes (Fig. 3A
and B) suggests a more solvent-exposed status of MalK
within the complex. Moreover, this status is not drastically
altered when ATP is bound as indicated by the failure of
MgATP to increase the percentage of extractable MalK.
Possibly, these differing results reflect specific structural
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requirements of MalK to perform its regulatory functions.
These involve physical interactions with cytoplasmic pro-
teins at its C-terminal domain which is lacking in HisP
[9,15,47].
Reassembly of a functional complex from MalK-de-
pleted proteoliposomes and purified MalK occurred linearly
and specifically as demonstrated by our failure to detect
association of MalK (at low concentrations) with pure lipid
vesicles (Fig. 4A, insert). Moreover, recovery of ATPase
activity was saturatable but with no indication of positive
cooperativity. Rebinding of MalK was also independent of
added MgATP which appears to be in contrast to findings by
Mourez et al. [22] who observed a stimulatory effect of
MgATP on reconstitution of MalK with MalFG-containing
membrane vesicles. However, in their study, membranes
were prepared from a strain lacking the malK gene, thus
producing MalFG subcomplexes that, unlike in proteolipo-
somes, were never in contact with MalK before. It seems not
unreasonable to assume that such ‘naı¨ve’ MalFG proteins
might preferentially recognize the ATP-bound form of MalK
[22,48] in the initial assembly process.
Recent experiments by Kennedy and Traxler [20] sug-
gested that assembly of the maltose transport complex in
vivo requires the formation of a MalK dimer that is formed
independently of MalFG. In contrast, in case of the histidine
transporter, assembly is viewed to occur by recruiting HisP
subunits independent of each other. This conclusion was
drawn from the finding that the amount of HisP rebound to
HisP-depleted HisQM-containing membranes increased lin-
early, while the ATPase activity of the restored transport
complex increased sigmoidally with the amount of HisP
added, indicating that the HisP subunits are dimerized
(activated) only while in contact with HisQM [40]. By
using a similar in vitro approach, our data are in support
of the former view, since the observed increase in recon-
stituted ATPase activity upon rebinding of MalK to MalFG-
containing proteoliposomes was clearly noncooperative
(Fig. 5). These apparent discrepancies are most likely
explained by assuming that, unlike HisP, MalK already
exists in dimeric form at rather low protein concentrations.
This notion is consistent with the finding by Kennedy and
Traxler [20] who also observed formation of heterodimers
of MalK and a variant in vitro by simply mixing crude cell
extracts. Moreover, pre-existing dimers would also explain
the linear dependency of the ATPase activity on increasing
MalK concentrations in solution (unpublished results).
Taken together, we have succeeded in the dissociation and
functional reassembly of the maltose transporter in proteo-
liposomes. The protocol provides a valuable tool for further
studying the interactions between the subunits at the level of
purified components, for example, by means of monoclonal
antibodies, competing synthetic peptides or site-specific
crosslinking.
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